Skip to main content

Abscint

ABSCINT is a molecular imaging company. ABSCINT has two lead programs in clinical stage, one in cardiovascular disease and one in oncology. The focus of ABSCINT is on single domain antibodies for diagnostics. The technology is used for detection of disease, patient stratification and treatment guidance and evaluation.
Read More

Win-TPS

Tools and methods towards the exploitation of a cyclotron-based hadrontherapy facility Hadrontherapy aims at treating cancers by irradiating tumor cells with protons or light ions (carbon), offering increased precision and significant biological gain on specific tumor cases. IBA is designing a new machine capable of treating patients with protons and...
Read More

Gage

Gallium-68 Automated Generator and Equipment En tomographie par émission de positons (TEP), le fluor 18F est largement utilisé en raison de ses propriétés chimiques et radiophysiques favorables. Néanmoins, il nécessite la proximité d’un cyclotron en raison de sa demi-vie de 110 minutes. Le gallium-68, avec sa demi-vie de 68 minutes,...
Read More

RadioTarget

New 188Re-radiolabelled monoclonal antibodies in the fight against liver metastases Early diagnosis of primary cancer, prior to any extension beyond the organ in which it was originally developed, usually allows treatment with surgical resection. However, significant proportions of patients with colorectal, breast or ovary cancers develop spread to the liver...
Read More

Mirror

Medical Resource Real-Time Optimizer The project was born from interactions betweenmembers ofthe young PALANTIRIS company and IBA, both companiesfacing the limitations of traditional workflow management techniques when it comes to orchestrate complex processes in a hospital service. Such processes involve numerous shared resources(rooms, diagnostics,treatment equipment,…) within stricttiming constraints and in...
Read More